Intellectual Property Attorneys

Photo

The New Patent Law in New Zealand

The USPTO's January 7, 2019 Revised Patent Subject Matter Eligibility Guidance

Filing of U.S. Provisional Patent Applications in Languages Other Than English

Patent Opposition Procedure Returns to the Japanese Patent Office

Foreign Applicant Filing of Provisional Patent Applications - Post-AIA Considerations

Patent Claims Directed to Electromagnetic Radiation - Adaptive Approaches

Pharmaceutical Dose Forms – Design Patent and Trademark Intellectual Property

Hultquist IP Client ABL Enters Collaboration with Roche Diagnostics International

Avoiding Patent-Eligibility Issues Under 35 USC 101 in Chemical and Biotechnology Patent Applications Involving Patient Response and Genotype Assays

Strategic Focus in the New Patent World of First-to-File

The Prior User Defense to Patent Infringement Liability Under the AIA - Basic Considerations

FINAL ALERT – THE NEW PATENT ERA BEGINS MARCH 16, 2013

European Union Parliament Approves Unitary European Patent/Unified European Patent Court Package

Preemptive Drafting Approaches to Negative Claim Limitations That May Be Added in Post-Filing Prosecution

THE 2013 TAIWAN PATENT LAW REVISIONS

A Vote For Unity – The Emergence Of The Eurocentral Patent Court And Unitary European Patent

Korean Patent Act and Korean Pharmaceutical Affairs Act Revisions to Implement Korea-US Free Trade Agreement (KORUS FTA)

The Calculus of Patent Versus Trade Secret Protection Under the Newly Revised U.S. Patent Law

America Invents Act (“AIA”) – The Emergent Landscape of the Revised U.S. Patent Law

America Invents Act - PTO Fees Increase 15% on September 26, 2011

June 8, 2011 Amendment of the Japanese Patent Law

Branding And Minimizing The Risk Of Trademark Squatting In Foreign Markets

Ariad v. Lilly - Underscoring the Fundamentals

The U.S. Patent Law and US FDA Law - Pharmaceutical Patent Strategies

Streamlining Trademark Application Processing and Lowering Filing Costs

Korea Moves to Implement an “Orange Book”-Type Registration System for Patents Covering Approved Pharmaceuticals